AIMab-7195

N/A

Report date: 2022/01/17 12:14:22

Base Information

Drug NameAIMab-7195
Drug Alias NameXmAb-7195AIMab-7195
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor II-b antagonistsImmunoglobulin E inhibitors
TargetsImmunoglobulin ELow affinity immunoglobulin gamma Fc region receptor II-b
Therapy Area/IndicationsFood HypersensitivityDermatitis, AtopicConjunctivitis, Allergic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesAimmune Therapeutics Inc
Inactive CompaniesXencor Inc
Active IndicationsFood Hypersensitivity
Inactive IndicationsDermatitis, AtopicConjunctivitis, AllergicRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A